Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
DOF ranks 1st in Korea Brand Preference Award for three consecutive years 2019-11-14 21:00
Samsung Biologics Enhances Its Trusted Service as the First and Only ISO27001 Certified CDMO 2019-11-14 20:00
111 Signs Strategic Partnership with HEC Group to Strengthen Cooperation with Innovative Pharmaceutical Manufacturer 2019-11-14 16:35
China Biologic Reports Financial Results for the Third Quarter of 2019 2019-11-14 05:43
TenNor Therapeutics Reported Phase II Top-Line Results for TNP-2092 2019-11-11 21:00
Akesobio Presents Phase 1 Clinical Data from First-in-class Bispecific Drug Candidate AK104 (PD1/CTLA4) As Oral Presentation, at 2019 SITC Annual Meeting 2019-11-11 17:35
Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent 2019-11-08 03:00
Enzene Opens its First Continuous Biologics Manufacturing Facility With a Promise to Disrupt the mAb Manufacturing Cost 2019-11-07 20:24
TransThera Biosciences Lead Product TT-00420 Granted Orphan Drug Designation from FDA to Treat Cholangiocarcinoma 2019-11-07 20:08
MEBO Group exhibits new products on CIIE again to promote the internationalization of traditional Chinese medicines (TCMS) 2019-11-07 14:43
Polynoma Presenting Interim Phase III Data for Its Investigational Melanoma Vaccine, Seviprotimut-L, at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2019-11-06 20:00
WuXi AppTec Receives Investment Grade Corporate Ratings from Three Global Rating Agencies 2019-11-06 16:00
Hebron Technology Co., Ltd. to Hold Annual Meeting of Shareholders on December 20, 2019 2019-11-06 05:05
Samsung Biologics and Ichnos Sciences Announce Agreement for Manufacture of ISB 830 2019-11-05 08:22
Mum Hails $10 Childs Farm Skincare Products "Life-changing" After They Clear Her Daughter's Severe Eczema 2019-11-05 03:00
Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation 2019-11-05 00:39
China Biologic Products to Report Third Quarter 2019 Financial Results 2019-11-04 21:30
Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults 2019-11-01 04:35
Icon Group Expands Cancer Care Capabilities with Purchase of Varian Adaptive Therapy Solution 2019-10-31 04:05
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
1 218 219 220 221 222 436